117 related articles for article (PubMed ID: 29346498)
1. Association of Treatment for Hodgkin Lymphoma With Estrogen Receptor Status of Subsequent Breast Cancers.
Withrow DR; Morton LM; Curtis RE; Schonfeld SJ; Berrington de González A
JAMA Oncol; 2018 Mar; 4(3):414-416. PubMed ID: 29346498
[TBL] [Abstract][Full Text] [Related]
2. Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma.
Travis LB; Hill D; Dores GM; Gospodarowicz M; van Leeuwen FE; Holowaty E; Glimelius B; Andersson M; Pukkala E; Lynch CF; Pee D; Smith SA; Van't Veer MB; Joensuu T; Storm H; Stovall M; Boice JD; Gilbert E; Gail MH
J Natl Cancer Inst; 2005 Oct; 97(19):1428-37. PubMed ID: 16204692
[TBL] [Abstract][Full Text] [Related]
3. Variation in the risk of radiation-related contralateral breast cancer by histology and estrogen receptor expression in SEER.
Neta G; Anderson WF; Gilbert E; Berrington A
Breast Cancer Res Treat; 2012 Feb; 131(3):1021-7. PubMed ID: 22015617
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic features of breast cancers diagnosed in women treated with prior radiation therapy for Hodgkin lymphoma: Results from a population-based cohort.
Wong SM; Ajjamada L; Weiss AC; Prakash I; Skamene S; Boileau JF; Pollak MN; Basik M
Cancer; 2022 Apr; 128(7):1365-1372. PubMed ID: 34919263
[TBL] [Abstract][Full Text] [Related]
5. Late effects of treatment for childhood Hodgkin's disease.
Travis LB; Curtis RE; Boice JD
N Engl J Med; 1996 Aug; 335(5):352-3. PubMed ID: 8668223
[No Abstract] [Full Text] [Related]
6. High burden of subsequent malignant neoplasms and cardiovascular disease in long-term Hodgkin lymphoma survivors.
de Vries S; Schaapveld M; van Nimwegen FA; Jóźwiak K; Lugtenburg PJ; Daniëls LA; Roesink JM; van der Maazen RWM; Kok WEM; Aleman BMP; van Leeuwen FE
Br J Cancer; 2018 Mar; 118(6):887-895. PubMed ID: 29381685
[TBL] [Abstract][Full Text] [Related]
7. Risk of breast cancer according to clinicopathologic features among long-term survivors of Hodgkin's lymphoma treated with radiotherapy.
Dores GM; Anderson WF; Beane Freeman LE; Fraumeni JF; Curtis RE
Br J Cancer; 2010 Sep; 103(7):1081-4. PubMed ID: 20842115
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer after Hodgkin disease: hope for a safer cure.
Yahalom J
JAMA; 2003 Jul; 290(4):529-31. PubMed ID: 12876097
[No Abstract] [Full Text] [Related]
9. Hormone receptor status of contralateral breast cancers: analysis of data from the US SEER population-based registries.
Mezencev R; Švajdler M
Breast Cancer; 2017 May; 24(3):400-410. PubMed ID: 27502779
[TBL] [Abstract][Full Text] [Related]
10. Incidence of breast cancer among female survivors of Hodgkin lymphoma: a US-population-based trend analysis from 1973 to 2011.
Giri S; Pathak R; Martin MG; Bhatt VR
Blood; 2015 Oct; 126(15):1861-3. PubMed ID: 26282539
[No Abstract] [Full Text] [Related]
11. Elevated risks of subsequent endometrial cancer development among breast cancer survivors with different hormone receptor status: a SEER analysis.
Liu J; Jiang W; Mao K; An Y; Su F; Kim BY; Liu Q; Jacobs LK
Breast Cancer Res Treat; 2015 Apr; 150(2):439-45. PubMed ID: 25764167
[TBL] [Abstract][Full Text] [Related]
12. Risk of Second Primary Female Genital Malignancies in Women with Breast Cancer: a SEER Analysis.
Li Z; Wu Q; Song J; Zhang Y; Zhu S; Sun S
Horm Cancer; 2018 Jun; 9(3):197-204. PubMed ID: 29556910
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease.
Travis LB; Hill DA; Dores GM; Gospodarowicz M; van Leeuwen FE; Holowaty E; Glimelius B; Andersson M; Wiklund T; Lynch CF; Van't Veer MB; Glimelius I; Storm H; Pukkala E; Stovall M; Curtis R; Boice JD; Gilbert E
JAMA; 2003 Jul; 290(4):465-75. PubMed ID: 12876089
[TBL] [Abstract][Full Text] [Related]
14. Changes in the use of radiation therapy for early classical Hodgkin lymphoma in adolescents and young adults: implications for survival and second malignancies.
Xavier AC; Costa LJ
Leuk Lymphoma; 2015; 56(8):2339-43. PubMed ID: 25393805
[TBL] [Abstract][Full Text] [Related]
15. Secondary Breast Cancer Risk by Radiation Volume in Women With Hodgkin Lymphoma.
Conway JL; Connors JM; Tyldesley S; Savage KJ; Campbell BA; Zheng YY; Hamm J; Pickles T
Int J Radiat Oncol Biol Phys; 2017 Jan; 97(1):35-41. PubMed ID: 27979454
[TBL] [Abstract][Full Text] [Related]
16. Risk of second malignancies in patients with early-stage classical Hodgkin's lymphoma treated in a modern era.
LeMieux MH; Solanki AA; Mahmood U; Chmura SJ; Koshy M
Cancer Med; 2015 Apr; 4(4):513-8. PubMed ID: 25620577
[TBL] [Abstract][Full Text] [Related]
17. Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia: a population-based study.
Hisada M; Chen BE; Jaffe ES; Travis LB
J Natl Cancer Inst; 2007 Feb; 99(3):215-22. PubMed ID: 17284716
[TBL] [Abstract][Full Text] [Related]
18. Radiation therapy in Hodgkin disease: why risk a Pyrrhic victory?
Longo DL
J Natl Cancer Inst; 2005 Oct; 97(19):1394-5. PubMed ID: 16204683
[No Abstract] [Full Text] [Related]
19. Lung cancer and other second neoplasms after treatment of Hodgkin lymphoma.
Almagro-Casado E; Sánchez A; Cantos B; Salas C; Pérez-Callejo D; Provencio M
Clin Transl Oncol; 2016 Jan; 18(1):99-106. PubMed ID: 26530956
[TBL] [Abstract][Full Text] [Related]
20. Inducing or Preventing Subsequent Malignancies for Breast Cancer Survivors? Double-edged Sword of Estrogen Receptor and Progesterone Receptor.
Hu ZY; Xiao H; Xiao M; Tang Y; Sun J; Xie ZM; Ouyang Q
Clin Breast Cancer; 2018 Oct; 18(5):e1149-e1163. PubMed ID: 29885789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]